Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)

被引：4
|
作者：
Yang, Yue [1 ]
Luo, Yi-Dan [1 ]
Zhang, Chen-Bo [1 ]
Xiang, Yang [1 ,2 ]
Bai, Xin-Yue [1 ]
Zhang, Die [1 ]
Fu, Zhao-Ying [1 ]
Hao, Ruo-Bing [1 ]
Liu, Xiao-Long [1 ]
机构：
[1] Yanan Univ, Sch Med, Yanan 716000, Peoples R China
[2] Yanan Univ, Coll Phys Educ, Yanan 716000, Peoples R China
来源：
ACS OMEGA | 2024年 / 9卷 / 32期
关键词：
RESPIRATORY SYNDROME-CORONAVIRUS; PAPAIN-LIKE PROTEASE; COVALENT INHIBITORS; WITHANIA-SOMNIFERA; DISCOVERY; DESIGN; AGLYCONE; BAICALIN;
D O I：
10.1021/acsomega.4c03023
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Since 2019, the novel coronavirus (SARS-CoV-2) has caused significant morbidity and millions of deaths worldwide. The Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2 and its variants, has further highlighted the urgent need for the development of effective therapeutic agents. Currently, the highly conserved and broad-spectrum nature of main proteases (M-pro) renders them of great importance in the field of inhibitor study. In this study, we categorize inhibitors targeting M-pro into three major groups: mimetic, nonmimetic, and natural inhibitors. We then present the research progress of these inhibitors in detail, including their mechanism of action, antiviral activity, pharmacokinetic properties, animal experiments, and clinical studies. This review aims to provide valuable insights and potential avenues for the development of more effective antiviral drugs against SARS-CoV-2.
引用
收藏
页码：34196 / 34219
页数：24
相关论文
共 50 条
  • [31] Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
    Johansen-Leete, Jason
    Ullrich, Sven
    Fry, Sarah E.
    Frkic, Rebecca
    Bedding, Max J.
    Aggarwal, Anupriya
    Ashhurst, Anneliese S.
    Ekanayake, Kasuni B.
    Mahawaththa, Mithun C.
    Sasi, Vishnu M.
    Luedtke, Stephanie
    Ford, Daniel J.
    O'Donoghue, Anthony J.
    Passioura, Toby
    Larance, Mark
    Otting, Gottfried
    Turville, Stuart
    Jackson, Colin J.
    Nitsche, Christoph
    Payne, Richard J.
    CHEMICAL SCIENCE, 2022, 13 (13) : 3826 - 3836
  • [32] Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease
    Son Tung Ngo
    Ngoc Quynh Anh Pham
    Ly Thi Le
    Duc-Hung Pham
    Vu, Van V.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (12) : 5771 - 5780
  • [33] Noncovalent Inhibitors of SARS-CoV-2 Main Protease: A Rescaffolding Attempt
    Krischuns, Tim
    Paisant, Sylvain
    Chen, Kuang-Yu
    Thirion, Laura N.
    Zettor, Agnes
    Chiaravalli, Jeanne
    Jacob, Yves
    Bellinzoni, Marco
    Naffakh, Nadia
    Janin, Yves L.
    SYNTHESIS-STUTTGART, 2025,
  • [34] Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (Mpro) inhibitors
    Hicks, Emily G.
    Kandel, Sylvie E.
    Lampe, Jed N.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 66
  • [35] A review of the latest research on Mpro targeting SARS-COV inhibitors
    Yang, Huihui
    Yang, Jinfei
    RSC MEDICINAL CHEMISTRY, 2021, 12 (07): : 1026 - 1036
  • [36] Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
    Yang, Xinbo
    Xing, Xianrong
    Liu, Yirui
    Zheng, Yuanjie
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] DFT Calculations and In silico Study of Chlorogenic, Ellagic and Quisqualic acids as Potential Inhibitors of SARS-CoV-2 Main Protease Mpro
    Shahab, Siyamak
    Kaviani, Sadegh
    Sheikhi, Masoome
    Almodarresiyeh, Hora Alhosseini
    Al Saud, Sultan
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2022, 12 (01): : 61 - 73
  • [38] Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
    Douangamath, Alice
    Fearon, Daren
    Gehrtz, Paul
    Krojer, Tobias
    Lukacik, Petra
    Owen, C. David
    Resnick, Efrat
    Strain-Damerell, Claire
    Aimon, Anthony
    Abranyi-Balogh, Peter
    Brandao-Neto, Jose
    Carbery, Anna
    Davison, Gemma
    Dias, Alexandre
    Downes, Thomas D.
    Dunnett, Louise
    Fairhead, Michael
    Firth, James D.
    Jones, S. Paul
    Keeley, Aaron
    Keserue, Gyoergy M.
    Klein, Hanna F.
    Martin, Mathew P.
    Noble, Martin E. M.
    O'Brien, Peter
    Powell, Ailsa
    Reddi, Rambabu N.
    Skyner, Rachael
    Snee, Matthew
    Waring, Michael J.
    Wild, Conor
    London, Nir
    von Delft, Frank
    Walsh, Martin A.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [39] Potential SARS-CoV-2 protease Mpro inhibitors: repurposing FDA-approved drugs
    Kouznetsova, Valentina L.
    Huang, David Z.
    Tsigelny, Igor F.
    PHYSICAL BIOLOGY, 2021, 18 (02)
  • [40] Structural biology of SARS-CoV-1/SARS-CoV-2 main protease
    Gao, Yunyun
    Kaub, Johannes
    Santoni, Gianluca
    Pearce, Nicholas
    Thorn, Andrea
    CRYSTALLOGRAPHY REVIEWS, 2023, 29 (02) : 76 - 101
12345